We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Soft Supercapacitor Could Power Implantable Devices

By HospiMedica International staff writers
Posted on 28 Nov 2023

The field of bioelectronic devices is rapidly advancing, offering new possibilities for health monitoring and the treatment of diseases. More...

A critical aspect of these devices is their power source. Now, researchers have made a significant breakthrough by developing a novel way to power implantable devices using a supercapacitor. This technology differs from traditional batteries, which store chemical energy. Supercapacitors, on the other hand, store electrical energy directly, offering advantages in terms of flexibility and weight.

The soft, implantable supercapacitor that can power implantable devices was developed by a team of bioengineers from China in collaboration with researchers at Pennsylvania State University (University Park, PA, USA). In order to be used for powering implantable devices, a supercapacitor must be biodegradable as well as harmless to the patient as it degrades. The newly developed soft, implantable supercapacitor is unique because every component is biodegradable and safe for the patient as it breaks down. The design includes a zinc foil as the anode, molybdenum sulfide as the cathode, and an alginate gel serving as the electrolyte. For wireless charging, a magnesium coil is placed on the skin above where the supercapacitor is implanted in the body.

Prior to its application, the supercapacitor underwent rigorous testing to ensure its degradation remained within safe health limits. It was then paired with a previously developed implantable medication dispenser, also biodegradable, for a practical test. The combined device was implanted in mice with fever induced by yeast infections. The medication was dispensed by the device, leading to a noticeable reduction in the severity of the fevers in the mice treated. While these initial results are promising, the researchers recognize that further work is needed before this technology is ready for human use. For instance, they have yet to develop a mechanism to deactivate the supercapacitor after its intended use. This highlights the ongoing journey in bioelectronics towards creating efficient, safe, and patient-friendly implantable devices.

Related Links:
Pennsylvania State University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Enteral Feeding Pump
Instilar 1420
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.